Patent · US Expired

Enhanced triple-helix and double-helix formation with oligomers containing modified purines

US5594121A · kind A · utility

587Cited by
14References
58Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 1995
Grant dateJan 14, 1997
Priority date
Expiry dateJun 7, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/6839
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel oligomers are disclosed which have enhanced ability with respect to forming duplexes or triplexes compared with oligomers containing only conventional bases. The oligomers contain 7-deaza-7-substituted purines or related analogs. The oligomers of the invention are capable of (i) forming triplexes with various target sequences such as virus or oncogene sequences by coupling into the major groove of a target DNA duplex at physiological pH or (ii) forming duplexes by binding to single-stranded DNA or to RNA encoded by target genes. The oligomers of the invention can be constructed to have any desired sequence, provided the sequence normally includes one or more bases that is replaced with the analogs of the invention. Compositions of the invention can be used for diagnostic purposes in order to detect viruses or disease conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.